{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:20:08Z","timestamp":1789676408052,"version":"4.0.1"},"reference-count":46,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK121140"],"award-info":[{"award-number":["DK121140"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK121844"],"award-info":[{"award-number":["DK121844"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK132879"],"award-info":[{"award-number":["DK132879"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32HL160520"],"award-info":[{"award-number":["5T32HL160520"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["9-22-PDFPM-01"],"award-info":[{"award-number":["9-22-PDFPM-01"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["10.58275\/aha.23divsup1074485.pc.gr.168377"],"award-info":[{"award-number":["10.58275\/aha.23divsup1074485.pc.gr.168377"],"id":[{"id":"10.58275\/aha.23divsup1074485.pc.gr.168377","id-type":"DOI","asserted-by":"publisher"}]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["908952"],"award-info":[{"award-number":["908952"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>\n                    Together with obesity and type 2 diabetes, metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global epidemic. Activation of the complement system and infiltration of macrophages has been linked to progression of metabolic liver disease. The role of complement receptors in macrophage activation and recruitment in MASLD remains poorly understood. In human and mouse,\n                    <jats:italic>C3AR1<\/jats:italic>\n                    in the liver is expressed primarily in Kupffer cells, but is downregulated in humans with MASLD compared to obese controls. To test the role of complement 3a receptor (C3aR1) on macrophages and liver resident macrophages in MASLD, we generated mice deficient in C3aR1 on all macrophages (C3aR1-M\u03c6KO) or specifically in liver Kupffer cells (C3aR1-KpKO) and subjected them to a model of metabolic steatotic liver disease. We show that macrophages account for the vast majority of\n                    <jats:italic>C3ar1<\/jats:italic>\n                    expression in the liver. Overall, C3aR1-M\u03c6KO and C3aR1-KpKO mice have similar body weight gain without significant alterations in glucose homeostasis, hepatic steatosis and fibrosis, compared to controls on a MASLD-inducing diet. This study demonstrates that C3aR1 deletion in macrophages or Kupffer cells, the predominant liver cell type expressing\n                    <jats:italic>C3ar1<\/jats:italic>\n                    , has no significant effect on liver steatosis, inflammation or fibrosis in a dietary MASLD model.\n                  <\/jats:p>","DOI":"10.7554\/elife.100708","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T07:25:50Z","timestamp":1727335550000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.100708","source":"Crossref","is-referenced-by-count":1,"title":["Complement 3a receptor 1 on macrophages and Kupffer cells is not required for the pathogenesis of metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.7554","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2923-9635","authenticated-orcid":true,"given":"Edwin A","family":"Homan","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r109517","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Cardiology, Department of Medicine, Cardiovascular Research Institute, Weill Center for Metabolic Health, Weill Cornell Medicine","place":["New York, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Ankit","family":"Gilani","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r109517","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Cardiology, Department of Medicine, Cardiovascular Research Institute, Weill Center for Metabolic Health, Weill Cornell Medicine","place":["New York, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Alfonso","family":"Rubio-Navarro","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r109517","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Cardiology, Department of Medicine, Cardiovascular Research Institute, Weill Center for Metabolic Health, Weill Cornell Medicine","place":["New York, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Maya A","family":"Johnson","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r109517","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Cardiology, Department of Medicine, Cardiovascular Research Institute, Weill Center for Metabolic Health, Weill Cornell Medicine","place":["New York, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Odin M","family":"Schaepkens","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r109517","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Cardiology, Department of Medicine, Cardiovascular Research Institute, Weill Center for Metabolic Health, Weill Cornell Medicine","place":["New York, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Eric","family":"Cortada","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r109517","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Cardiology, Department of Medicine, Cardiovascular Research Institute, Weill Center for Metabolic Health, Weill Cornell Medicine","place":["New York, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Renan","family":"Pereira de Lima","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r109517","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Cardiology, Department of Medicine, Cardiovascular Research Institute, Weill Center for Metabolic Health, Weill Cornell Medicine","place":["New York, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Lisa","family":"Stoll","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r109517","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Cardiology, Department of Medicine, Cardiovascular Research Institute, Weill Center for Metabolic Health, Weill Cornell Medicine","place":["New York, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0244-1670","authenticated-orcid":true,"given":"James C","family":"Lo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r109517","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Cardiology, Department of Medicine, Cardiovascular Research Institute, Weill Center for Metabolic Health, Weill Cornell Medicine","place":["New York, United States"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]}],"member":"4374","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41574-022-00675-6","type":"journal-article","article-title":"Macrophage functional diversity in NAFLD - more than inflammation","volume":"18","author":"Barreby","year":"2022","journal-title":"Nature Reviews. Endocrinology"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.3748\/wjg.v25.i33.4904","type":"journal-article","article-title":"Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source","volume":"25","author":"Boland","year":"2019","journal-title":"World Journal of Gastroenterology"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/hep.30506","type":"journal-article","article-title":"The role of innate immune cells in nonalcoholic steatohepatitis","volume":"70","author":"Cai","year":"2019","journal-title":"Hepatology"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41590-021-00926-0","type":"journal-article","article-title":"Dynamic regulation of B cell complement signaling is integral to germinal center responses","volume":"22","author":"Cumpelik","year":"2021","journal-title":"Nature Immunology"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","type":"journal-article","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the american heart association","volume":"42","author":"Duell","year":"2022","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","type":"journal-article","article-title":"Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus","volume":"17","author":"Ferguson","year":"2021","journal-title":"Nature Reviews. Endocrinology"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.3299706","type":"journal-article","article-title":"Severely impaired adipsin expression in genetic and acquired obesity","volume":"237","author":"Flier","year":"1987","journal-title":"Science"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","type":"journal-article","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nature Medicine"},{"key":"bib9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-036663","type":"journal-article","article-title":"Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990-2017: a population-based observational study","volume":"10","author":"Ge","year":"2020","journal-title":"BMJ Open"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/s41591-019-0610-4","type":"journal-article","article-title":"Adipsin preserves beta cells in diabetic mice and associates with protection from type 2 diabetes in humans","volume":"25","author":"G\u00f3mez-Banoy","year":"2019","journal-title":"Nature Medicine"},{"key":"bib11","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aba4448","type":"journal-article","article-title":"Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis","volume":"12","author":"Govaere","year":"2020","journal-title":"Science Translational Medicine"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","type":"journal-article","article-title":"Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches","volume":"185","author":"Guilliams","year":"2022","journal-title":"Cell"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.immuni.2022.08.002","type":"journal-article","article-title":"Liver macrophages in health and disease","volume":"55","author":"Guilliams","year":"2022","journal-title":"Immunity"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/path.5275","type":"journal-article","article-title":"Bone marrow-derived macrophage contributes to fibrosing steatohepatitis through activating hepatic stellate cells","volume":"248","author":"Han","year":"2019","journal-title":"The Journal of Pathology"},{"key":"bib15","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.653293","type":"journal-article","article-title":"Complement component c3: a novel biomarker participating in the pathogenesis of non-alcoholic fatty liver disease","volume":"8","author":"Han","year":"2021","journal-title":"Frontiers in Medicine"},{"key":"bib16","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-020-01356-2","type":"journal-article","article-title":"Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis","volume":"20","author":"Hansen","year":"2020","journal-title":"BMC Gastroenterology"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","type":"journal-article","article-title":"NAFLD and cardiovascular diseases: a clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clinical Research in Cardiology"},{"key":"bib18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094495","type":"journal-article","article-title":"Metabolic spectrum of liver failure in type 2 diabetes and obesity: from NAFLD to NASH to HCC","volume":"22","author":"Kim","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"bib19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00001","type":"journal-article","article-title":"Keeping it all going-complement meets metabolism","volume":"8","author":"Kolev","year":"2017","journal-title":"Frontiers in Immunology"},{"key":"bib20","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112078","type":"journal-article","article-title":"Loss of C3a and C5a receptors promotes adipocyte browning and attenuates diet-induced obesity via activating inosine\/A2aR pathway","volume":"42","author":"Kong","year":"2023","journal-title":"Cell Reports"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1136\/gutjnl-2019-318382","type":"journal-article","article-title":"Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis","volume":"69","author":"Krenkel","year":"2020","journal-title":"Gut"},{"key":"bib22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0286257","type":"journal-article","article-title":"A new NASH model in aged mice with rapid progression of steatohepatitis and fibrosis","volume":"18","author":"Li","year":"2023","journal-title":"PLOS ONE"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1096\/fj.12-220582","type":"journal-article","article-title":"C5aR and C3aR antagonists each inhibit diet\u2010induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling","volume":"27","author":"Lim","year":"2013","journal-title":"The FASEB Journal"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cell.2014.06.005","type":"journal-article","article-title":"Adipsin is an adipokine that improves \u03b2 cell function in diabetes","volume":"158","author":"Lo","year":"2014","journal-title":"Cell"},{"key":"bib25","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.178925","type":"journal-article","article-title":"Adipsin and adipocyte-derived C3aR1 regulate thermogenic fat in a sex-dependent fashion","volume":"9","author":"Ma","year":"2024","journal-title":"JCI Insight"},{"key":"bib26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06318-7","type":"journal-article","article-title":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations","volume":"9","author":"MacParland","year":"2018","journal-title":"Nature Communications"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.2337\/db09-0323","type":"journal-article","article-title":"The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation","volume":"58","author":"Mamane","year":"2009","journal-title":"Diabetes"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2353\/ajpath.2007.070166","type":"journal-article","article-title":"The role of complement in inflammatory diseases from behind the scenes into the spotlight","volume":"171","author":"Markiewski","year":"2007","journal-title":"The American Journal of Pathology"},{"key":"bib29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00262","type":"journal-article","article-title":"Complement system part i - molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Frontiers in Immunology"},{"key":"bib30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1150118","type":"journal-article","article-title":"Major roles of kupffer cells and macrophages in NAFLD development","volume":"14","author":"Park","year":"2023","journal-title":"Frontiers in Endocrinology"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.metabol.2015.11.006","type":"journal-article","article-title":"Adipokines in nonalcoholic fatty liver disease","volume":"65","author":"Polyzos","year":"2016","journal-title":"Metabolism"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.immuni.2019.09.002","type":"journal-article","article-title":"Liver-derived signals sequentially reprogram myeloid enhancers to initiate and maintain kupffer cell identity","volume":"51","author":"Sakai","year":"2019","journal-title":"Immunity"},{"key":"bib33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110053","type":"journal-article","article-title":"Complement alternative pathway activation in human nonalcoholic steatohepatitis","volume":"9","author":"Segers","year":"2014","journal-title":"PLOS ONE"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","type":"journal-article","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"The Lancet. Diabetes & Endocrinology"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"G462","DOI":"10.1152\/ajpgi.00358.2018","type":"journal-article","article-title":"Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals","volume":"316","author":"Suppli","year":"2019","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41586-018-0590-4","type":"journal-article","article-title":"Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris","volume":"562","author":"The Tabula Muris Consortium","year":"2018","journal-title":"Nature"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","type":"journal-article","article-title":"A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","volume":"69","author":"Tsuchida","year":"2018","journal-title":"Journal of Hepatology"},{"key":"bib38","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419","type":"journal-article","article-title":"Proteomics: tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s42255-024-01043-6","type":"journal-article","article-title":"An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"6","author":"Vacca","year":"2024","journal-title":"Nature Metabolism"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"14577","DOI":"10.1073\/pnas.261428398","type":"journal-article","article-title":"Complement activation in factor D-deficient mice","volume":"98","author":"Xu","year":"2001","journal-title":"PNAS"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"4956","DOI":"10.1016\/j.cell.2023.09.020","type":"journal-article","article-title":"Molecular basis of anaphylatoxin binding, activation, and signaling bias at complement receptors","volume":"186","author":"Yadav","year":"2023","journal-title":"Cell"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","type":"journal-article","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"key":"bib43","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.im1401s83","type":"journal-article","article-title":"The isolation and characterization of murine macrophages","volume":"83","author":"Zhang","year":"2008","journal-title":"Current Protocols in Immunology"},{"key":"bib44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1054159","type":"journal-article","article-title":"Association of complement components with the risk and severity of NAFLD: a systematic review and meta-analysis","volume":"13","author":"Zhao","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"dataset1","type":"dataset","article-title":"Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals","volume-title":"NCBI Gene Expression Omnibus","author":"Suppli","year":"2019","unstructured":"Suppli MP, Rigbolt KTG, Veidal SS, Heeb\u00f8ll S, Eriksen PL, Demant M, Bagger JI, Nielsen JC, Or\u00f3 D, Thrane SW, Lund A, Strandberg C, K\u00f8nig MJ, Vilsb\u00f8ll T, Vrang N, Thomsen KL, Gr\u00f8nb\u00e6k H, Jelsing J, Hansen HH, Knop FK. 2019. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals. NCBI Gene Expression Omnibus. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE126848. GSE126848."},{"key":"dataset2","type":"dataset","article-title":"Tabula Muris: Transcriptomic characterization of 20 organs and tissues from Mus musculus at single cell resolution","volume-title":"NCBI Gene Expression Omnibus","author":"The Tabula Muris Consortium","year":"2018","unstructured":"The Tabula Muris Consortium. 2018. Tabula Muris: Transcriptomic characterization of 20 organs and tissues from Mus musculus at single cell resolution. NCBI Gene Expression Omnibus. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE109774. GSE109774."}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/100708\/elife-100708-v1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/100708\/elife-100708-v1.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/100708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:53:01Z","timestamp":1787565181000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/100708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":46,"alternative-id":["10.7554\/eLife.100708"],"URL":"https:\/\/doi.org\/10.7554\/elife.100708","archive":["CLOCKSS"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.06.26.24309550","asserted-by":"subject"},{"id-type":"doi","id":"10.1101\/2024.06.26.24309550","asserted-by":"object"}],"references":[{"id-type":"accession","id":"GSE126848","asserted-by":"subject"},{"id-type":"accession","id":"GSE109774","asserted-by":"subject"}],"is-same-as":[{"id-type":"doi","id":"10.7554\/eLife.100708.3","asserted-by":"subject"}],"is-version-of":[{"id-type":"doi","id":"10.7554\/eLife.100708.1","asserted-by":"subject"},{"id-type":"doi","id":"10.7554\/eLife.100708.2","asserted-by":"subject"}],"is-financed-by":[{"id-type":"doi","id":"10.58275\/aha.23divsup1074485.pc.gr.168377","asserted-by":"subject"},{"id-type":"doi","id":"10.58275\/AHA.23DIVSUP1074485.pc.gr.168377","asserted-by":"object"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"RP100708"}}